Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124869293 | 12486929 | 3 | F | 2015 | 20160725 | 20160621 | 20160803 | EXP | CA-AMGEN-CANSP2016075157 | AMGEN | 72.00 | YR | E | F | Y | 0.00000 | 20160803 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124869293 | 12486929 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK, QWK | U | 103795 | UNKNOWN FORMULATION | /wk | |||||||
| 124869293 | 12486929 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 5 MG, ONCE DAILY | 0 | 5 | MG | QD | |||||||
| 124869293 | 12486929 | 3 | C | METHOTREXATE. | METHOTREXATE | 1 | Oral | 15 MG, QWK | 0 | 15 | MG | /wk | |||||||
| 124869293 | 12486929 | 4 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 80 MG, QD | 0 | 80 | MG | QD | |||||||
| 124869293 | 12486929 | 5 | C | SANDOZ CANDESARTAN | 2 | Oral | 8 MG, QD | 0 | 8 | MG | QD | ||||||||
| 124869293 | 12486929 | 6 | C | SANDOZ AMLODIPINE | AMLODIPINE MALEATE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
| 124869293 | 12486929 | 7 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | 5 MG, QD (6 DAYS PER WEEK) | 0 | 5 | MG | QD | |||||||
| 124869293 | 12486929 | 8 | C | SANDOZ PANTOPRAZOL | 2 | Oral | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 124869293 | 12486929 | 9 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | 81 MG, QD | 0 | 81 | MG | QD | |||||||
| 124869293 | 12486929 | 10 | C | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Oral | UNK UNK, AS NECESSARY | 0 | ||||||||||
| 124869293 | 12486929 | 11 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 100/25 MG, ONCE DAILY | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124869293 | 12486929 | 1 | Rheumatoid arthritis |
| 124869293 | 12486929 | 2 | Product used for unknown indication |
| 124869293 | 12486929 | 3 | Rheumatoid arthritis |
| 124869293 | 12486929 | 5 | Blood pressure increased |
| 124869293 | 12486929 | 6 | Blood pressure increased |
| 124869293 | 12486929 | 10 | Pain |
| 124869293 | 12486929 | 11 | Blood pressure increased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124869293 | 12486929 | OT |
| 124869293 | 12486929 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124869293 | 12486929 | Cerebrovascular accident | |
| 124869293 | 12486929 | Joint swelling | |
| 124869293 | 12486929 | Pain | |
| 124869293 | 12486929 | Peripheral swelling | |
| 124869293 | 12486929 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |